GeneTex
  • Country / Location Selection

United States (US)
Recombinant Antibodies

Recombinant Antibodies

Recombinant Antibodies

 

Section 1.

What is a recombinant antibody?

Section 2.

GeneTex’s Recombinant Monoclonal Antibody Production Initiative

 
Section 3.

Why GeneTex’s rabbit-based HL clones are a better choice.

Section 4.

IVD-related Applications for GeneTex’s Recombinant Antibodies

 

See all related Products

 

section1

Section 1. What is a recombinant antibody?

A recombinant antibody (rAb) is generated from the cloned, in vitro-expressed heavy and light chains of a selected monoclonal antibody obtained through classical hybridoma methodology, display strategies alone or in combination, sorted single B cells from immunized animals, or by one of many other techniques. The fact that it is cloned means the rAb is defined by its primary sequence, which can be engineered to optimize affinity and be expressed in different binder formats. The numerous advantages of rAbs have been well-documented, with consistency of performance being of paramount significance.

GeneTex’s rAb protocol employs a multi-parameter FACS-based approach to isolate antigen-specific IgG+ memory B cells from an immunized animal, with subsequent cloning of the antibody variable-region genes into an IgG backbone and expression in mammalian cells (Fig. 1) (1). This protocol is very rapid and can be completed in weeks, and also affords the opportunity to identify antibodies with diverse capabilities in various applications. Importantly, it allows cloning of the heavy and light chains from the same B cell, thereby preserving natural pairing. And once cloned, the supply of a given rAb is inexhaustible with exceptional reproducibility.

 

(A)
(B)

Figure 1. (A) The GeneTex recombinant rabbit monoclonal antibody workflow (Starkie et al. (2016)). (B) Advantages of recombinant antibodies.

One outstanding advantage of this protocol is that the suitability of the individual clones for desired applications can be tested during screening. For example, GeneTex’s Iba1 rabbit recombinant antibody [HL22] (GTX635363) detects Iba1, a protein commonly used as an immunohistochemical marker of both quiescent and activated microglia. In its development and production, both paraffin- and frozen-IHC analyses (IHC-P, IHC-Fr, respectively) were conducted in the first screening process to identify the best clones for these applications, as shown below (Fig. 2). The clones were compared to a highly cited, market-leading commercial antibody to gauge their performance. This strategy provides us with valuable perspective on a clone’s market competitiveness during development. In addition, our recombinant antibody team has successfully expressed the antigen-binding regions of this antibody in the context of both mouse and rat IgG backbones, thus extending flexibility for multiplexed staining.

 

Figure 2. GeneTex's recombinant rabbit monoclonal Iba1 antibody [HL22] (GTX635363) is superior to a competitor's highly cited rabbit polyclonal antibody for both IHC-P (panels A vs. D) and IHC-Fr (panels B, C vs. E, F).

Another new recombinant rabbit monoclonal reagent is GeneTex’s RAS (G12D mutant) antibody [HL10] (GTX635362) (Fig. 3). It demonstrates a robust signal and specificity for the G12D mutation in wild-type (WT) and KRAS G12D mutant pancreatic tumor tissue sections (Fig. 3A) and in established cell line lysates (Fig. 3B), respectively. This RAS (G12D mutant) antibody (GTX635362) is the first commercial recombinant version that shows exceptional specificity by IHC-P for this key tumorigenic mutant protein on sequence-verified human pancreatic tumor samples.

 

Figure 3. (A) GeneTex's recombinant rabbit RAS (G12D mutant) antibody [HL10] (GTX635362) is sensitive and specific for the RAS G12D mutation by IHC of a KRAS G12D mutant pancreatic tumor tissue section (top) compared to a wild-type KRAS section (bottom). (B) The antibody is sensitive and specific for the RAS G12D mutation by WB of extracts from wild-type and mutant KRAS-confirmed human pancreatic cell lines. GAPDH for the loading control was detected by GTX100118. Lane1: HPDE. Lane2: HPNE. Lane3: AsPC1 (KRAS G12D). Lane4: BxPC3 (KRAS WT). Lane5: CFPAC1 (KRAS G12V). Lane6: HPAC (KRAS G12D). Lane7: HPAF-II (KRAS G12D). Lane8: MIA PaCa-22 (KRAS G12C). Lane9: PANC1 (KRAS G12D). Lane10: SU86.86 (KRAS G12D).

As mentioned above, the antigen-binding regions of a recombinant antibody can be inserted into various host IgG backbones or expressed in different binder formats (e.g., Fab fragments or scFvs). Here, GeneTex’s cloned TSG101 mouse monoclonal antibody (GTX70255) was converted to a rabbit IgG backbone (GTX635396) with preservation of performance. No cross-reaction was observed when the converted TSG101 rabbit IgG recombinant antibody was used in combination with an anti-mouse IgG secondary antibody (Fig. 4).

 

Figure 4. Backbone switch from a cloned mouse IgG antibody to a rabbit IgG antibody.

Literature:

Flyer - Recombinant Abs

Brochure-Recombinant Antibodies

Reference:

  1. PLoS One.2016; 11(3): e0152282.

| TOP |

 

 

section2

Section 2. GeneTex’s Recombinant Monoclonal Antibody Production Initiative

GeneTex’s production focus is the creation of novel recombinant rabbit monoclonal antibodies validated using enhanced protocols defined by the International Working Group for Antibody Validation (IWGAV).

Over the last decade, studies published in many of the top scientific journals have clearly described the significant impact of poorly validated antibody reagents on the reproducibility of biomedical research. The unfortunate reality is that the commercial antibody market is compromised by a substantial subset of products that have been demonstrated to be nonspecific. This means that there are two major issues that must be addressed in order to improve the overall quality of the commercial antibody market and therefore the integrity and reproducibility of the biomedical research dependent on antibodies. The first is more widespread adoption of production platforms that emphasize recombinant antibody technology (please see “Section 1: What is a recombinant antibody?”) while the second involves incorporation of improved and more coherent validation strategies. GeneTex is making major strides in both of these endeavors. 

With the goal of providing better products for its customers through innovative technology, GeneTex has now shifted all of its new production to recombinant rabbit monoclonal antibodies (please see “Section 3: Why GeneTex’s rabbit-based HL clones are a better choice.”). Fully recombinant antibodies are defined by their primary sequence, their consistent performance and supply (issues that plague traditional polyclonals and hybridoma-based monoclonals with regard to lot-to-lot variability), and their ability to be engineered (i.e., backbone switching) to meet researcher requirements. These benefits may even evoke more favorable impressions by grant review and journal editorial committees. Other outstanding advantages of recombinant rabbit antibodies stem from the favorable biological characteristics of the rabbit immune system itself.

In conjunction with its pivot to recombinant antibody production, GeneTex’s second commitment to antibody reliability is its incorporation of enhanced validation protocols, based on the IWGAV proposal mentioned above, into its manufacturing and quality assurance (QA) workflow (1). This involves evaluation of each antibody using at least one, and preferably more, of five validation “pillars” defined in the IWGAV study. GeneTex’s version of the IWGAV plan follows the five standard strategies and includes (1) Knockout/Knockdown; (2) Comparable Antibodies; (3) Immunoprecipitation followed by Mass Spectrometry (IP/MS); (4) Biological and Orthogonal Validation; and (5) Recombinant Protein Expression (Fig. 1). The company refers to this as its “5+1” Pillar Plan when referencing new recombinant antibody production, with the “+1” designation referring to the pre-validation that is inherent in the application-specific assessment that occurs with clone selection during the recombinant antibody production process (please see “New Validated Recombinant Monoclonal Antibodies from GeneTex” below).

The new recombinant rabbit monoclonal antibodies that have been generated and evaluated using the production and validation approaches described above (these products are identified by “HL” in their clone designations) are just the beginning. GeneTex is also working to replace its successful polyclonals with new recombinants. The company envisions the “HL” clones representing the highest level of GeneTex validation and manufacturing capability.

Antibody fidelity, application-dependent reliability, and performance and supply consistency are crucial for ensuring research integrity. GeneTex joins other reputable companies in leveraging recombinant antibody technology and enhanced validation to create antibodies that researchers can trust.

  

Figure 1.  GeneTex’s “5+1” Pillar Plan for recombinant antibody validation.

New Validated Recombinant Monoclonal Antibodies from GeneTex

  Knockout / Knockdown Validation

Complete removal or significant reduction of the endogenous signal following genetic strategies involving genome editing or RNA interference, respectively.

Integrin beta 1 / CD29 antibody [HL1255] (GTX636657)

  Comparable Antibodies

Independent antibodies against the same target but to different epitopes, often including distinct samples with different target protein expression levels.

Influenza A Virus Nucleoprotein antibody [HL1089] (GTX636247)

  Biological and Orthogonal Validation

Alterations in the endogenous level of the target protein in accordance with specific preparation conditions corresponding to defined biological characteristics, or comparison between antibody-dependent and -independent methods.

PARP antibody [HL1364] (GTX636804)

  Protein Overexpression

Tagged target proteins overexpressed in transfected cells are used as a positive control for validation.

AKT1 antibody [HL1142] (GTX636413)

  Recombinant Antibody

Antibody is generated using recombinant technology.

Gli1 antibody [HL247] (GTX635619)

Reference:

  1. Nat Methods. 2016 Oct;13(10):823-7.

| TOP |

 

 

 

section3

Section 3. Why GeneTex’s rabbit-based HL clones are a better choice.

GeneTex’s recombinant rabbit monoclonal antibody production process is the platform for all new rabbit-based antibody generation (1). These products are distinguished by the “HL” designation in their respective clone numbers (e.g., “[HL1089]”). The rabbit, and specifically its immune system, is known to confer the following outstanding benefits for monoclonal antibody creation: broader antibody range, less complex immunoglobulin (Ig) structure, higher binding affinities, larger pool of lymphocytes to select antibodies (2). Each of these advantages is described in more detail below:

 

1. Broader antibody repertoire:

  1. Rabbits belong to the order Lagomorpha, which is evolutionarily distinct from the order Rodentia. This means that human antigens present epitopes that are often more immunogenic in rabbits than in mice, expanding the number of generated antibodies that may in turn cross-react with murine protein orthologs (2-5).
  2. The rabbit immune system is more successful in mounting an immune response to hapten or small molecule antigens, which is frequently not the case with the murine immune system (2-5).
  3. Mice used to generate monoclonal antibodies are from inbred lines and offer less diversity in their immunogenic responses than do rabbits. In addition, mouse spleens are much smaller than rabbit spleens (2-5).
  4. The rabbit immune system is different from those of mice and humans in that it utilizes somatic gene conversion (SGC) to expand its antibody range in addition to performing the same VDJ and VJ recombination and somatic hypermutation (SHM) mechanisms noted in mice and humans. Antibody diversity is further enhanced by other processes that include a kappa light chain variable gene structure distinctive for variability in the length of complementarity determining region 3 (LCDR3), as well as successive Ig development in the bone marrow, the gut-associated lymphoid tissues (GALT), and spleen and lymph node germinal centers (3, 5).

 2. Simpler Ig structure:

  1. The European rabbit (Oryctolagus cuniculus) is known to have single genes for IgE and IgM, and no genes for IgD. Interestingly, its genome contains 13 IGHA genes coding for at least 10 functional IgA subclasses. Importantly, though there are allelic variants, rabbits have only one IgG gene (and thus no subclass) and therefore differ from mice and humans (each with four IgG subclasses) (4, 5).

  2. In addition to the disulfide bonds found in a human or mouse IgG (linking the heavy chain pair or one heavy chain to its associated light chain), rabbit IgG antibodies demonstrate a unique intrachain disulfide bond in their K1 light chain. This is significant as perhaps 90% of IgGs in New Zealand White rabbits are IgG-k (K1), and this extra bond is thought to confer stability onto the rabbit IgG (2, 5).

3. Enhanced binding affinity:

  1. Rabbit monoclonal antibodies have very high affinities with Kd values characteristically in the picomolar range, with some possessing exceptionally low picomolar Kd values (2, 5).

  2. Picomolar Kds translate to increased sensitivity with consistent specificity.

4. Larger lymphocyte pool:

  1. Rabbits have a longer life span and their larger size (perhaps a 100-fold weight differential between a three-month-old rabbit and a six-week-old mouse) greatly facilitates blood and tissue sampling during antibody production (5).

  2. Consistent with the statements above, rabbit spleens allow isolation of 50-fold more B cells compared to murine spleens, meaning more clones recognizing a wider selection of epitopes (2-5).

GeneTex hopes that the distinct advantages of rabbit monoclonal antibodies discussed above will encourage you to consider our HL clones for your research needs. As GeneTex has now shifted all of its new antibody production to the creation of these monoclonal antibodies, our product inventory will continue to expand rapidly moving forward.

 

 

GeneTex’s Well-validated HL Clone Antibodies

ACE2 antibody [HL1092]   (GTX636265)

Vimentin antibody [HL1506] (GTX636980)

ERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [HL173] (GTX635617)

NRF2 antibody [HL1021] (GTX635826)

p70 S6K (phospho Thr421/Ser424) antibody [HL129] (GTX635621)

PD-L1 antibody [HL1041] (GTX635975)

 

References:

  1. PLoS One. 2016 Mar 29;11(3):e0152282. doi: 10.1371/journal.pone.0152282. eCollection 2016.
  2. Am J Transl Res. 2011 May 15;3(3):269-74. Epub 2011 Apr 23.
  3. Comp Immunol.2006;30(1-2):137-53. doi: 10.1016/j.dci.2005.06.017.
  4. Immunogenetics. 2016 Feb;68(2):83-107. doi: 10.1007/s00251-015-0868-8.
  5. Exp Mol Med.2017 Mar; 49(3): e305. doi: 10.1038/emm.2017.23.

| TOP |

 

 

 

section4

Section 4. IVD-related Applications for GeneTex’s Recombinant Antibodies

 

Advantages:

  • Superior Quality
  • Performance Consistency
  • Bulk Production (gram quantities)
  • International QMS Certifications:
  • ISO 9001:2015
 
  • ISO 13485:2016
 

 

  • Production in QMS IVD Laboratory
  • Validated Antibody Pairs for IVD
  • Product Development and Services

 

IVD-related Services:

  1. Lateral Flow Assay (LFA) Development Service
  2. Enzyme-Linked Immunosorbent Assay (ELISA) Development Service
  3. Immunohistochemistry (IHC)-Validated Recombinant Antibodies

 

 

 

Influenza A Virus (FluA)

Capture:
Influenza A Virus Nucleoprotein antibody
[HL1078] (GTX636199)

Detection:
Influenza A Virus Nucleoprotein antibody
[HL1953] (GTX637790)

Samples:
1. FluA Nucleoprotein (H1N1) (GTX135904-pro)
2. FluA Nucleoprotein (H3N2) (GTX136317-pro)
3. Lysis buffer

Influenza B Virus (FluB)

Capture:
Influenza B Virus Nucleoprotein antibody
[HL1069] (GTX636100)

Detection:
Influenza B Virus Nucleoprotein antibody
[HL1068] (GTX636099)

Samples:
1. Influenza B Virus Nucleoprotein (B/Victoria/02/1987) (GTX136277-pro)
2. Influenza B Virus Nucleoprotein (B/Sydney/3/2004) (GTX135867-pro)
3. Lysis buffer

Respiratory Syncytial Virus (RSV)

Capture:
Respiratory Syncytial Virus Nucleoprotein
antibody [HL1248] (GTX636650)

Detection:
Respiratory Syncytial Virus Nucleoprotein
antibody [HL1246] (GTX636648)

Samples:
1. RSV type A Nucleoprotein (GTX136751-pro)
2. RSV type B Nucleoprotein (GTX136931-pro)
3. SARS-CoV-2 Nucleocapsid protein (GTX135592-pro)
4. FluA (H1N1) Nucleoprotein (GTX135904-pro)
5. FluA (H3N2) Nucleoprotein (GTX135903-pro)
6. FluB Nucleoprotein (GTX136277-pro)
7. Lysis buffer

SARS-CoV-2 (COVID-19)

Capture:
SARS-CoV-2 (COVID-19) Nucleocapsid antibody
[HL455] (GTX635688)

Detection:
SARS-CoV-2 (COVID-19) Nucleocapsid antibody
[HL448] (GTX635686)

Samples:
1. SARS-CoV-2 (COVID-19) Nucleocapsid protein (GTX135592-pro)
2. Lysis buffer

African Swine Fever Virus

Capture:
ASFV p54 antibody [HL1287]
(GTX636701)

Detection:
ASFV p54 antibody [GT1075]
(GTX635691)

Samples:
1. ASFV p54 (ECD) protein, His Tag (GTX135175-pro)
2. Lysis buffer

Human Papillomavirus type 16 E7

Capture:
Human Papillomavirus type 16 E7 antibody
[HL1647] (GTX637228)

Detection:
Human Papillomavirus type 16 E7 antibody
[HL1821] (GTX637546)

Samples:
1. HPV16 E7 protein (GTX133411-pro)
2. HPV18 E7 protein (GTX133412-pro)
3. Lysis buffer

 

 

 

Direct/Indirect ELISA

Virus subtype detection

Direct/Indirect ELISA

EC50 determination

Sandwich ELISA

Target protein detection and quantitation

Sandwich ELISA

Antibody pair screening

Competitive ELISA

Neutralizing antibody evaluation

 

 

 
     

 

| TOP |

 

 

Literature
Flyer - Hybridoma Conversion to Recombinant Antibody Service

Flyer - Hybridoma Conversion to Recombinant Antibody Service

Literature

Flyer - Recombinant Monoclonal Antibodies Against G Protein-Coupled Receptors

Download the latest version of GeneTex's Recombinant Monoclonal Antibodies Against G Protein-Coupled Receptors flyer.
Newsletter
Article Alert: LSD1 Inhibition Suppresses Glucocorticoid-induced Muscle Atrophy while Preserving Anti-inflammatory Activity

LSD1 Inhibition Suppresses Glucocorticoid-induced Muscle Atrophy.

Article Alert: LSD1 Inhibition Suppresses Glucocorticoid-induced Muscle Atrophy while Preserving Anti-inflammatory Activity
Literature

Flyer - Recombinant Monoclonal Antibodies for Cell Markers

Download the latest version of GeneTex's Recombinant Monoclonal Antibodies for Cell Markers flyer.
Newsletter
Article Alert: Macrophage-expressed TM4SF19 is a Major Factor in Chronic Inflammation and Metabolic Dysfunction Caused by Obesity

TM4SF19 in Macrophages Regulates Chronic Inflammation and Metabolic Dysfunction Caused by Obesity

Newsletter
Article Alert: Induced Proteasomal Degradation of TET2 Leads to EGFR-Tyrosine Kinase Inhibitor Resistance In Non-Small Cell Lung Cancer

Induced Proteasomal Degradation of TET2 Leads to EGFR-Tyrosine Kinase Inhibitor Resistance In NSCLC

Article Alert: Induced Proteasomal Degradation of TET2 Leads to EGFR-Tyrosine Kinase Inhibitor Resistance In Non-Small Cell Lung Cancer
Literature

Flyer - IVD-related Products

Download the latest version of GeneTex's IVD-related Products flyer.
Literature
Flyer - HistoMAX – IHC-validated Antibodies

Flyer - HistoMAX – IHC-validated Antibodies

Literature

Flyer - Cited Antibodies 2024 Q2

Download the latest version of GeneTex's Antibodies for Cited Antibodies 2024 Q2 flyer.
Newsletter
Article Alert: Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Ductal Adenocarcinoma

Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Cancer

Newsletter
Article Alert: Stromal Monoamine Oxidase B Drives Prostate Cancer

Article Alert: Stromal Monoamine Oxidase B Drives Prostate Cancer

Newsletter
Article Alert: SUN2 Induces Cytoskeleton Rearrangement via Nesprins and NS1 to Promote Flavivirus Replication

SUN2 Induces Cytoskeleton Rearrangement via Nesprins and NS1 to Promote Flavivirus Replication

Literature

Poster - The Tumor Microenvironment (TME) - Part 2

Download the latest version of GeneTex's The Tumor Microenvironment (TME) - Part 2 poster.
Literature

Poster - The Tumor Microenvironment (TME) - Part 1

Download the latest version of GeneTex's The Tumor Microenvironment (TME) - Part 1 poster.
Literature

Poster - Cancer-associated-cells

Download the latest version of GeneTex's cancer-associated-cells poster.
Literature

Poster - Pre-Metastatic Niche

Download the latest version of GeneTex's Pre-Metastatic Niche poster.
Newsletter
Article Alert: Exosomal lnc-MLETA1 Promotes Lung Cancer Metastasis

Article Alert: Exosomal lnc-MLETA1 Promotes Lung Cancer Metastasis

Articles

IVD-related Products and Services

Newsletter
Article Alert: An anti-VEGFR2 F(ab')2 Drug Conjugate as a Therapeutic Agent for Diabetic Nephropathy

Article Alert: An anti-VEGFR2 F(ab')2 Drug Conjugate as a Therapeutic Agent for Diabetic Nephropathy

Literature

Flyer - Validated Antibodies for Canine and Feline Research

Download the latest version of GeneTex's Validated Antibodies for Canine and Feline Research flyer.
Literature

Flyer-Selected Antibodies for Influenza Virus

Download the latest version of GeneTex's Selected Antibodies for Influenza Virus flyer.
Literature

Poster - Neuronal and Glial Markers

Download the latest version of GeneTex's neuronal and glial markers poster.
Newsletter
GeneTex's New S100 beta Recombinant Monoclonal Antibody

GeneTex's New S100 beta Recombinant Monoclonal Antibody

Newsletter
Article Alert: Capsid-dependent Choreography of HIV-1 Nuclear Entry

Article Alert: Capsid-dependent Choreography of HIV-1 Nuclear Entry

Newsletter
GeneTex Addresses GPCR Targets with its Recombinant Monoclonal Antibody Production Platform

GeneTex Addresses GPCR Targets with its Recombinant Monoclonal Antibody Production Platform

Literature
IHC-Validated Recombinant Antibodies

IHC-Validated Recombinant Antibodies

Newsletter
GeneTex's KO-Validated RGS4 Recombinant Monoclonal Antibody

GeneTex's KO-Validated RGS4 Recombinant Monoclonal Antibody

Literature
Flyer - Hybridoma Conversion to Recombinant Antibody Service

Flyer - Hybridoma Conversion to Recombinant Antibody Service

Literature

Flyer - Recombinant Monoclonal Antibodies Against G Protein-Coupled Receptors

Download the latest version of GeneTex's Recombinant Monoclonal Antibodies Against G Protein-Coupled Receptors flyer.
Literature

Flyer - Recombinant Monoclonal Antibodies for Cell Markers

Download the latest version of GeneTex's Recombinant Monoclonal Antibodies for Cell Markers flyer.
Literature

Flyer - IVD-related Products

Download the latest version of GeneTex's IVD-related Products flyer.
Literature
Flyer - HistoMAX – IHC-validated Antibodies

Flyer - HistoMAX – IHC-validated Antibodies

Literature

Flyer - Cited Antibodies 2024 Q2

Download the latest version of GeneTex's Antibodies for Cited Antibodies 2024 Q2 flyer.
Literature

Poster - The Tumor Microenvironment (TME) - Part 2

Download the latest version of GeneTex's The Tumor Microenvironment (TME) - Part 2 poster.
Literature

Poster - The Tumor Microenvironment (TME) - Part 1

Download the latest version of GeneTex's The Tumor Microenvironment (TME) - Part 1 poster.
Literature

Poster - Cancer-associated-cells

Download the latest version of GeneTex's cancer-associated-cells poster.
Literature

Poster - Pre-Metastatic Niche

Download the latest version of GeneTex's Pre-Metastatic Niche poster.
Literature

Flyer - Validated Antibodies for Canine and Feline Research

Download the latest version of GeneTex's Validated Antibodies for Canine and Feline Research flyer.
Literature

Flyer-Selected Antibodies for Influenza Virus

Download the latest version of GeneTex's Selected Antibodies for Influenza Virus flyer.
Literature

Poster - Neuronal and Glial Markers

Download the latest version of GeneTex's neuronal and glial markers poster.
Literature
IHC-Validated Recombinant Antibodies

IHC-Validated Recombinant Antibodies

Literature

Brochure - Featured Antibodies

Download the latest version of GeneTex's Featured Antibodies brochure.
Literature
Lateral Flow Assay (LFA)  Development Service

Flyer-Lateral Flow Assay (LFA) Development Service

Download the latest version of GeneTex's Lateral Flow Assay (LFA) Development Service flyer.
Literature

Flyer-Metabolism

Download the latest version of GeneTex's Metabolism flyer.
Literature

Flyer-Virology

Download the latest version of GeneTex's Virology flyer.
Literature

Flyer-Antibodies for Neuroscience Research

Download the latest version of GeneTex's Antibodies for Neuroscience Research flyer.
Literature

Poster - Mitochondria Metabolism

Download the latest version of GeneTex's Mitochondria Metabolism poster.
Literature

Flyer-Total Solutions of Antibodies for SARS CoV-2

Download the latest version of GeneTex's Total Solutions of Antibodies for SARS CoV-2 flyer.
Literature
Neuroscience Research

Pamphlet - Neuroscience Research

Download the latest version of GeneTex's neuroscience research pamphlet.
Literature

Flyer-Neuroscience

Download the latest version of GeneTex's Neuroscience flyer.
Literature
Brochure - Recombinant Antibodies

Brochure - Recombinant Antibodies

Download the latest version of GeneTex's Recombinant Antibodies brochure.
Literature
Brochure - Cited Antibodies

Brochure - Cited Antibodies

Download the latest version of GeneTex's Cited Antibodies brochure.
Literature

Brochure - Antibodies For Virology Research

Download the latest version of GeneTex's Antibodies For Virology Research brochure.
Literature
Pamphlet - SARS-CoV-2 (COVID-19) Research Reagents

Pamphlet - SARS-CoV-2 (COVID-19) Research Reagents

SARS-CoV-2 (COVID-19) Research Reagents
Literature

Brochure-Tumor-markers

Download the latest version of GeneTex's Tumor markers brochure.
Literature
Brochure - SARS-CoV-2 (COVID-19) Research

Brochure - SARS-CoV-2 (COVID-19) Research

Download the latest version of GeneTex's SARS-CoV-2 (COVID-19) Research brochure.
Literature

Flyer-Cell Biology

Download the latest version of GeneTex's Cell Biology flyer.
Literature

Flyer-Cancer

Download the latest version of GeneTex's Cancer flyer.
Literature
Download the latest version of GeneTex's Recombinant antibodies flyer.

Flyer - Recombinant Abs

Download the latest version of GeneTex's Recombinant antibodies flyer.
Literature
Cancer Immune Checkpoints

Flyer - Cancer Immune Checkpoints

Download the latest version of GeneTex's cancer immune checkpoint flyer
Literature

Flyer- Drosophila Antibodies

Download the latest version of GeneTex's Drosophila Antibodies flyer.
Literature

Flyer- Virology Research_DM

Download the latest version of GeneTex's Virology Research flyer.
Literature
Flyer - mTOR Signaling Pathway

Flyer - mTOR Signaling Pathway

Download the latest version of GeneTex's mTOR signaling pathway flyer.
Literature

Flyer-Wnt Signaling

Download the latest version of GeneTex's Wnt Signaling flyer.
Literature

Pamphlet - Antibodies for Hypoxia Research

Download the latest version of GeneTex's Antibodies for Hypoxia Research pamphlet.
Literature

Flyer-MAPK Pathway

Download the latest version of GeneTex's MAPK Pathway flyer.
Literature
Pancreatic Cancer Tumor Markers

Flyer - Pancreatic Cancer Tumor Markers

Download the latest version of GeneTex's Pancreatic Cancer Tumor Markers flyer.
Literature
Download the latest version of GeneTex's Angiogenesis flyer.

Flyer - Angiogenesis

Download the latest version of GeneTex's Angiogenesis flyer.
Literature
Download the latest version of GeneTex's Zika Virus Research flyer.

Flyer-Zika Virus Research

Download the latest version of GeneTex's Zika Virus Research flyer.
Literature
Selected Antibodies for Influenza Virus

Flyer-Selected Antibodies for Influenza Virus

Download the latest version of GeneTex's Selected Antibodies for Influenza Virus flyer.
Literature
Download the latest version of GeneTex's Custom Antibody Services flyer.

Custom Antibody Services

Download the latest version of GeneTex's Custom Antibody Services flyer.
Literature
Cell Cycle

Flyer - Cell Cycle

Download the latest version of GeneTex's Cell Cycle flyer.
Literature
SARS-CoV-2 (COVID-19) poster

Poster - SARS-CoV-2 (COVID-19)

Download the latest version of GeneTex's SARS-CoV-2 (COVID-19) poster
Literature
Cited Antibodies

Flyer - Cited Antibodies

Download the latest version of GeneTex's cited antibodies flyer.
Literature
Pyroptosis_and_Inflammation

Flyer-Pyroptosis and Inflammation

Download the latest version of GeneTex's Pyroptosis and Inflammation flyer.
Literature
Obesity & Diabetes

Flyer - Obesity & Diabetes

Download the latest version of GeneTex's Obesity & Diabetes flyer.
Literature
Recombinant Active Proteins

Pamphlet - Recombinant Active Proteins

Download the latest version of GeneTex's Recombinant Active Proteins Pamphlet.
Literature

Flyer - Recombinant Monoclonal Antibodies for Protein Post-Translational Modifications (PTM)

Download the latest version of GeneTex's post-translational modifications flyer.
Literature
Cancer Stem Cells

Flyer - Cancer Stem Cells

Download the latest version of GeneTex's cancer stem cells flyer.
Literature
Neurodegenerative Disorders

Flyer - Neurodegenerative Disorders

Download the latest version of GeneTex's neurodegenerative disorders flyer.
Literature
Zebrafish

Flyer - Zebrafish

Download the latest version of GeneTex's zebrafish flyer.
Literature
Biological Research

Poster - Biological Research

Download the latest version of GeneTex's biological research poster
Literature
Exosome and Microvesicle Markers

Poster - Exosome and Microvesicle Markers

Download the latest version of GeneTex's exosome and microvesicle markers poster.
Literature

Poster - Zebrafish

Download the latest version of GeneTex's zebrafish poster.
Literature
Neurodegenerative Disorders

Poster - Neurodegenerative Disorders

Download the latest version of GeneTex's neurodegenerative disorders poster.
Literature
Immune Response

Poster - Immune Response

Download the latest version of GeneTex's immune response poster.
Literature
Epitope Tags and Reporters

Flyer - Epitope Tags and Reporters

Download the latest version of GeneTex's epitope tags and reporters flyer.
Literature
Organelle Markers

Poster - Organelle Markers

Download the latest version of GeneTex's organelle markers poster
Literature

Pamphlet - Hot Products

Download the latest version of GeneTex's pamphlet of hot products.
Literature
Hypoxia Regulation

Poster - Hypoxia Regulation

Download the latest version of GeneTex's hypoxia regulation poster
Protocols

Protocol - IHC (whole-mount)

Download GeneTex's IHC (whole-mount) Protocol.
Protocols

Protocol - Cytosolic-and Membrane Fractionation

Download GeneTex's Cytosolic-and Membrane Fractionation Protocol.
Newsletter
Article Alert: LSD1 Inhibition Suppresses Glucocorticoid-induced Muscle Atrophy while Preserving Anti-inflammatory Activity

LSD1 Inhibition Suppresses Glucocorticoid-induced Muscle Atrophy.

Article Alert: LSD1 Inhibition Suppresses Glucocorticoid-induced Muscle Atrophy while Preserving Anti-inflammatory Activity
Newsletter
Article Alert: Macrophage-expressed TM4SF19 is a Major Factor in Chronic Inflammation and Metabolic Dysfunction Caused by Obesity

TM4SF19 in Macrophages Regulates Chronic Inflammation and Metabolic Dysfunction Caused by Obesity

Newsletter
Article Alert: Induced Proteasomal Degradation of TET2 Leads to EGFR-Tyrosine Kinase Inhibitor Resistance In Non-Small Cell Lung Cancer

Induced Proteasomal Degradation of TET2 Leads to EGFR-Tyrosine Kinase Inhibitor Resistance In NSCLC

Article Alert: Induced Proteasomal Degradation of TET2 Leads to EGFR-Tyrosine Kinase Inhibitor Resistance In Non-Small Cell Lung Cancer
Newsletter
Article Alert: Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Ductal Adenocarcinoma

Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Cancer

Newsletter
Article Alert: Stromal Monoamine Oxidase B Drives Prostate Cancer

Article Alert: Stromal Monoamine Oxidase B Drives Prostate Cancer

Newsletter
Article Alert: SUN2 Induces Cytoskeleton Rearrangement via Nesprins and NS1 to Promote Flavivirus Replication

SUN2 Induces Cytoskeleton Rearrangement via Nesprins and NS1 to Promote Flavivirus Replication

Newsletter
Article Alert: Exosomal lnc-MLETA1 Promotes Lung Cancer Metastasis

Article Alert: Exosomal lnc-MLETA1 Promotes Lung Cancer Metastasis

Newsletter
Article Alert: An anti-VEGFR2 F(ab')2 Drug Conjugate as a Therapeutic Agent for Diabetic Nephropathy

Article Alert: An anti-VEGFR2 F(ab')2 Drug Conjugate as a Therapeutic Agent for Diabetic Nephropathy

Newsletter
GeneTex's New S100 beta Recombinant Monoclonal Antibody

GeneTex's New S100 beta Recombinant Monoclonal Antibody

Newsletter
Article Alert: Capsid-dependent Choreography of HIV-1 Nuclear Entry

Article Alert: Capsid-dependent Choreography of HIV-1 Nuclear Entry

Newsletter
GeneTex Addresses GPCR Targets with its Recombinant Monoclonal Antibody Production Platform

GeneTex Addresses GPCR Targets with its Recombinant Monoclonal Antibody Production Platform

Newsletter
GeneTex's KO-Validated RGS4 Recombinant Monoclonal Antibody

GeneTex's KO-Validated RGS4 Recombinant Monoclonal Antibody

Newsletter
GeneTex's KO-Validated CD44 Recombinant Monoclonal Antibody

GeneTex's KO-Validated CD44 Recombinant Monoclonal Antibody

Newsletter
GeneTex's GAD67 and GAD65 Recombinant Monoclonal Antibodies

GeneTex's GAD67 and GAD65 Recombinant Monoclonal Antibodies

Newsletter
GeneTex’s New Recombinant Monoclonal CD97/ADGRE5 Antibody

GeneTex’s New Recombinant Monoclonal CD97/ADGRE5 Antibody

Newsletter
New ARL13B Recombinant Monoclonal Antibody for  Cilia Research

New ARL13B Recombinant Monoclonal Antibody for Cilia Research

Newsletter
Single-Extracellular Vesicle Analysis (sEVA) to Detect Early Pancreatic Cancer

Single-Extracellular Vesicle Analysis (sEVA) to Detect Early Pancreatic Cancer

Newsletter
PARPs as Therapeutic Targets in Clinical Oncology

PARPs as Therapeutic Targets in Clinical Oncology

Newsletter

Detection of VEEV Nonstructural Proteins with GeneTex’s Recombinant Monoclonal Antibodies

Newsletter
Article Alert: Natural Compounds with Broad Antiviral Activity against SARS-CoV-2 VOCs

Article Alert: Natural Compounds with Broad Antiviral Activity against SARS-CoV-2 VOCs

Newsletter
Influenza A and B Virus Recombinant Monoclonal Antibodies

Influenza A and B Virus Recombinant Monoclonal Antibodies

Influenza A and B Virus Recombinant Monoclonal Antibodies
Newsletter
The SARS-CoV-2 Omicron Variant

The SARS-CoV-2 Omicron Variant

The SARS-CoV-2 Omicron Variant
Newsletter
HCK Inhibition: Boosting Immunotherapy’s Efficacy and Utility?

HCK Inhibition: Boosting Immunotherapy’s Efficacy and Utility?

Newsletter
Article Alert: C3aR and TNF-αR Antagonists as Potential Therapies for Medulloblastoma

Article Alert: C3aR and TNF-αR Antagonists as Potential Therapies for Medulloblastoma

Newsletter
E3 Ligase UBE3A Detection with GeneTex’s New Recombinant Antibody

E3 Ligase UBE3A Detection with GeneTex’s New Recombinant Antibody

Newsletter

GeneTex’s “5 + 1” Pillar Antibody Validation Plan

Newsletter

Omicron BQ.1 and BF.7 Spike and Nucleocapsid Recombinant Proteins

Newsletter
New Recombinant Rabbit Interleukin-6 (IL-6) Monoclonal Antibody

New Recombinant Rabbit Interleukin-6 (IL-6) Monoclonal Antibody

Interleukin-6 (IL-6) is a cytokine with a high clinical profile due to its involvement in inflammatory processes, autoimmune disease, and cancer progression....
Newsletter

A Rising StAR in Cancer Research

Steroidogenic acute regulatory protein 1 (StAR/StARD1) mediates the rate-limiting step in steroidogenesis...
Newsletter
SARS-CoV-2-directed T cell Response in Convalescent and Vaccinated Individuals

SARS-CoV-2-directed T cell Response in Convalescent and Vaccinated Individuals

SARS-CoV-2-directed T cell Response in Convalescent and Vaccinated Individuals
Newsletter
SARS-CoV-2 can infect the human brain

SARS-CoV-2 can infect the human brain

SARS-CoV-2 can infect the human brain
Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Newsletter
IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research
Newsletter

Lateral Flow Assay for Influenza & SARS-CoV-2 Viruses Detection

Influenza A & B Virus Antibodies (IVD grade)
Newsletter
New Therapeutic Paradigm for Cancers with Activated NRF2

New Therapeutic Paradigm for Cancers with Activated NRF2

New Therapeutic Paradigm for Cancers with Activated NRF2
Newsletter
Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes

Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes

Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes
Newsletter
Skin Regeneration without Scar Formation

Skin Regeneration without Scar Formation

Skin Regeneration without Scar Formation
Newsletter
mRNA Vaccine-induced Antibody Profiles against SARS-CoV-2 Variants

mRNA Vaccine-induced Antibody Profiles against SARS-CoV-2 Variants

mRNA Vaccine-induced Antibody Profiles against SARS-CoV-2 Variants
Newsletter
GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry

GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry

GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry
Newsletter

Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells

Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells
Newsletter

Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease

Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease
Newsletter
GeneTex Introduces Recombinant Monoclonal Iba1 Antibody

GeneTex Introduces Recombinant Monoclonal Iba1 Antibody

GeneTex's Iba1 recombinant antibody is suitable for IHC staining and WB.
Newsletter
GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]

GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]

GeneTex's RAS (G12D mutant) recombinant antibody is suitable for IHC staining and WB.
Newsletter

Leaky blood-brain barrier triggers neural dysfunction that is reversible

Leaky blood-brain barrier triggers neural dysfunction that is reversible
Newsletter
GeneTex Partners With BenchSci to Augment Antibody Catalog Publication Data

GeneTex Partners With BenchSci to Augment Antibody Catalog Publication Data

Partnership will use BenchSci's artificial intelligence to help researchers run successful experiments with the right antibody
Newsletter
GeneTex Webinar Series

GeneTex Webinar Series

GeneTex Webinar Series
Newsletter
SARS-CoV-2 Proteins and Antibodies for Lateral Flow-based Neutralization Assay

SARS-CoV-2 Proteins and Antibodies for Lateral Flow-based Neutralization Assay

for Lateral flow-based Neutralization Assay
Newsletter
Cancer Immunotherapy

A Cancer Immunotherapy Holy Grail?

A Cancer Immunotherapy Holy Grail?
Newsletter

MLLT3/AF9 is Pivotal for Human HSC Self-renewal and Engraftment

MLLT3/AF9 is Pivotal for Human HSC Self-renewal and Engraftment
Newsletter

Neurodegeneration: A "Vicious Cycle" Involving Mitochondria, Glia, and Neuronal Death

A "Vicious Cycle" Involving Mitochondria, Glia, and Neuronal Death
Newsletter

SETD3 Is Pivotal for Infection by Multiple Human Enteroviruses

In an exciting example of this concept, Diep et al. described the use of a genome-scale CRISPR screen to show that the protein histidine methyltransferase SETD3 is crucial for the replication of multiple human enteroviruses.
Newsletter

Soluble TREM2 is associated with clinical progression of Alzheimer’s disease.

A recent study by Ewers et al. reported that increased soluble TREM2 measured in cerebrospinal fluid was associated with lower rates of cognitive and clinical decline and progression in people with AD.
Newsletter
HBV

Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.

Is a cure for chronic hepatitis B on the horizon? Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.
Newsletter
exosome PD-L1

Improving cancer immunotherapy efficacy may depend on targeting exosomes

Improving cancer immunotherapy efficacy may depend on targeting exosomes bearing the immune checkpoint protein PD-L1